Back to Top Skip to main content

Vaccine-Preventable Diseases

Vaccines are essential to the Medically Ready Force.

Vaccines:

  • Are our best defenses against some still common and sometimes deadly diseases.
  • Prevent infections, such as tetanus, typhoid fever, measles, yellow fever, smallpox and anthrax, to name just a few.
  • Maintain the Medically Ready Force. We fight as a team. All team members must be healthy.
  • Help you return home healthy and help your family stay that way.

Vaccines are among the most important accomplishments in medicine. Vaccines have saved more lives throughout the world than any other medical invention, including antibiotics or surgery.  Only clean water has saved more lives than vaccines.

Click the following for more information:

Recommended Immunization Operations and Coronavirus Disease 2019 Pandemic (CAC authentication required)

Note: To access this information paper, click on the button above to go to the DHA Launchpad home page. Then click the "Latest Updates COVID-19" tile, and find the information paper under "Clinical Guidance and Operational Information."

Recommendations for Mass Immunization Events During Pandemic Conditions

Checklist: Best Practices for Vaccination Clinics
Held at Satellite, Temporary, or Off-Site Locations

Advisory Committee on Immunization Practices (ACIP) Recommendations

Advisory Committee on Immunization Practices (ACIP)
Vaccine-Specific Recommendations

DD Form 3110: Routine Immunization Screening Form: Pediatric

DD Form 3111: Routine Immunization Screening Form: Adult

(NOTE: The forms above are examples. The fillable, signable forms are available for individual download at Official DoD Website for DoD Forms.)

How to Use Standing Orders for Vaccine Delivery in the Department of Defense

Anatomic site maps: Suggested sites for immunizations

General Best Practice Guidelines for Vaccine Administration

Administering Vaccines to Adults: Dose, Route, Site, and Needle Size

DHA-IHD Information Papers (Overview of disease, vaccine, policy, etc.)

Centers for Disease Control and Prevention (CDC) Vaccine Information Statements

Food and Drug Administration-Approved Vaccine Package Inserts

TRICARE Retail Vaccination Program information

(NOTE: Be sure to call your pharmacy first to see if there are any restrictions and to make sure the vaccine you need is available. For TRICARE Benefit questions, please visit https://tricare.mil/immunizations.)

You also may be interested in...

Department of Defense Global, Laboratory-based Influenza Surveillance Program’s Influenza vaccine effectiveness estimates and surveillance trends, 2016 – 2017 Influenza Season

Infographic
2/5/2018
Each year, the Department of Defense (DoD) Global, Laboratory-based Influenza Surveillance Program performs surveillance for influenza among service members of the DoD and their dependent family members. In addition to routine surveillance, vaccine effectiveness (VE) studies are performed and results are shared with the Food and Drug Administration, Centers for Disease Control and Prevention, and the World Health Organization for vaccine evaluation. This report documents the annual surveillance trends for the 2016 – 2017 influenza season and the end-of-season VE results. The analysis was performed by the U.S. Air Force School of Aerospace Medicine Epidemiology Laboratory, and the DoD Influenza Surveillance Program staff at Wright-Patterson Air Force Base, OH. FINDINGS: A total of 5,555 specimens were tested from 84 locations: •	2,486 (44.7%) negative •	1,382 (24.9%) influenza A •	1,093 (19.7%) other respiratory pathogens •	443 (8.0%) influenza B •	151 (2.7%) co-infections The predominant influenza strain was A (H3N2), representing 73.8% of all circulating influenza. Pie chart displays this information. Graph showing the numbers and percentages of respiratory specimens positive for influenza viruses, and numbers of influenza viruses identified, by type, by surveillance week, Department of Defense healthcare beneficiaries, 2016 – 2017 influenza season displays. The vaccine effectiveness (VE) for this season was slightly lower than for the 2015 – 2016 season, which had a 63% (95% confidence interval: 53% - 71%) adjusted VE. The adjusted VE for the 2016 – 2017 season was 48% protective against all types of influenza.  Access the full report in the January 2018 MSMR (Vol. 25, No. 1). Go to: www.Health.mil/MSMR

This infographic documents the annual surveillance trends for the 2016 – 2017 influenza season and the end-of-season vaccine effectiveness.

Recommended Content:

Health Readiness | Influenza Summary and Reports | Medical Surveillance Monthly Report | Vaccine-Preventable Diseases | Force Health Protection | Global Health Engagement
Showing results 1 - 1 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.